Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in Cervical Spondylotic Myelopathy
NCT01257828Phase 3Completed
- Sponsor
- AO Spine North America Research Network
- Start
- Mar 2012
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of riluzole in cervical spondylotic myelopathy (CSM), sponsored by AO Spine North America Research Network. Started Mar 2012; status: completed.
02
Drugs
riluzole
03
Conditions
cervical spondylotic myelopathy (CSM)
Beyond the preview
Go deeper on NCT01257828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01257828.